GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Minnesota dad who shoved conservative reporter says he’s second-guessing living in US after backlash
Minnesota father, Chris Ostroushko, accused of assaulting a TPUSA reporter, Savanah Hernandez, at an anti-ICE protest says he has been overwhelmed by the "nonstop" backlash against his family....
The crew of the Mariana notified the U.S. Coast Guard on April 15 that the 145-foot vessel lost its starboard engine during Super Typhoon Sinlaku....
The official X account of Israel, which is run by the Israeli Foreign Ministry, promoted an upcoming four-day LGBTQ pride festival in June at the Dead Sea....
